Entero Healthcare Solutions Ltd
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India[1]
- Market Cap ₹ 4,863 Cr.
- Current Price ₹ 1,118
- High / Low ₹ 1,258 / 970
- Stock P/E 124
- Book Value ₹ 377
- Dividend Yield 0.00 %
- ROCE 6.72 %
- ROE 4.98 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Stock is trading at 2.93 times its book value
- Company has low interest coverage ratio.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| 1,780 | 2,522 | 3,300 | 3,922 | |
| 1,758 | 2,498 | 3,236 | 3,810 | |
| Operating Profit | 22 | 24 | 64 | 112 |
| OPM % | 1% | 1% | 2% | 3% |
| 4 | 4 | 6 | 14 | |
| Interest | 20 | 29 | 49 | 66 |
| Depreciation | 16 | 20 | 24 | 25 |
| Profit before tax | -11 | -20 | -4 | 36 |
| Tax % | 42% | 49% | 201% | -12% |
| -15 | -29 | -11 | 40 | |
| EPS in Rs | -1,550.90 | -77.71 | -28.12 | 8.99 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 30% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 66% |
| TTM: | 452% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Equity Capital | 0 | 4 | 4 | 43 |
| Reserves | -32 | -62 | -73 | 1,595 |
| 720 | 974 | 1,101 | 338 | |
| 145 | 210 | 275 | 369 | |
| Total Liabilities | 833 | 1,125 | 1,308 | 2,345 |
| 189 | 262 | 268 | 289 | |
| CWIP | 2 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| 643 | 863 | 1,040 | 2,056 | |
| Total Assets | 833 | 1,125 | 1,308 | 2,345 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| -69 | -35 | -45 | -37 | |
| -31 | -162 | -49 | -705 | |
| 89 | 211 | 73 | 863 | |
| Net Cash Flow | -11 | 14 | -21 | 121 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 50 | 54 | 57 | 57 |
| Inventory Days | 54 | 49 | 41 | 43 |
| Days Payable | 22 | 22 | 25 | 24 |
| Cash Conversion Cycle | 82 | 81 | 73 | 77 |
| Working Capital Days | 84 | 79 | 72 | 71 |
| ROCE % | 1% | 5% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Jul - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015.
-
Announcement under Regulation 30 (LODR)-Acquisition
28 Jun - Entero Healthcare Solutions Limited ("Entero") has informed about acquisition of Devi Pharma Wellness Private Limited approved by the Board of Entero at its meeting held …
- Board Meeting Outcome for Outcome Of Board Meeting Held On June 28, 2024 28 Jun
- Closure of Trading Window 27 Jun
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Jun - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015
Concalls
-
Jun 2024Transcript PPT REC
-
May 2024TranscriptNotesPPT
-
Mar 2024Transcript PPT
Leading Healthcare Product Disributor[1] The company is among the top three healthcare distributors in India in terms of revenue. Further, it achieved the fastest scale-up of operations among healthcare product distributors in India between FY19 - FY22.